首页 > 最新文献

Malaysian Journal of Pharmaceutical Sciences最新文献

英文 中文
SYSTEMATIC REVIEW OF PHARMACIST-LED HOME MEDICATION REVIEWS TO IMPROVE ADHERENCE TO ANTIDIABETIC MEDICATIONS AMONG ADULT TYPE 2 DIABETES PATIENTS 由药剂师主导的家庭用药回顾以改善成年 2 型糖尿病患者的抗糖尿病药物依从性的系统性回顾
Pub Date : 2023-11-23 DOI: 10.21315/mjps2023.21.2.3
Mohd Shainol Azmar Kassim, Soo Pei Pei
Pharmacists can contribute to the improvement in diabetes management and help patients recognise and manage barriers to optimal medication adherence. Home medication review (HMR) services provided by pharmacists could also assist patients in minimising drugrelated problems. This systematic review aimed to evaluate and summarise evidence from recent literature on the effectiveness of pharmacist-led home medication review interventions to improve medication adherence in adult type-2 diabetes mellitus (T2DM) patients. Primary research articles published in English from 1st January 2012 to 31st May 2022, were retrieved from five online electronic databases (MEDLINE, Embase, Scopus, Cochrane Reviews and the Web of Science). The methodological quality of all included studies was assessed using the Critical Appraisal Skills Programme (CASP) checklists. The literature search identified 2,178 publications; only four were included in this review. All four studies found that pharmacist-led HMR was associated with significant positive changes in the patient’s medication adherence. Significant improvements were demonstrated either through self-reported medication adherence assessment questionnaires or the pill counting adherence ratio before and after HMR visits. There was evidence of statistically significant effectiveness of pharmacist-led HMR initiatives to improve patient adherence to medication among adult T2DM patients.
药剂师可为改善糖尿病管理做出贡献,并帮助患者识别和处理最佳服药习惯的障碍。药剂师提供的家庭用药检查(HMR)服务也能帮助患者尽量减少与药物有关的问题。本系统性综述旨在评估和总结近期文献中有关药剂师主导的家庭用药检查干预措施对改善成年 2 型糖尿病(T2DM)患者用药依从性的有效性的证据。我们从五个在线电子数据库(MEDLINE、Embase、Scopus、Cochrane Reviews 和 Web of Science)中检索了 2012 年 1 月 1 日至 2022 年 5 月 31 日期间发表的主要英文研究文章。所有纳入研究的方法学质量均采用批判性评估技能计划(CASP)核对表进行评估。文献检索共发现 2,178 篇文献,只有四篇被纳入本综述。所有四项研究均发现,药剂师指导的 HMR 与患者用药依从性的显著积极变化相关。通过自我报告的用药依从性评估问卷或 HMR 访问前后的药片计数依从性比率,均显示出显著的改善。有证据表明,药剂师指导的 HMR 对提高成年 T2DM 患者的用药依从性有显著的统计学效果。
{"title":"SYSTEMATIC REVIEW OF PHARMACIST-LED HOME MEDICATION REVIEWS TO IMPROVE ADHERENCE TO ANTIDIABETIC MEDICATIONS AMONG ADULT TYPE 2 DIABETES PATIENTS","authors":"Mohd Shainol Azmar Kassim, Soo Pei Pei","doi":"10.21315/mjps2023.21.2.3","DOIUrl":"https://doi.org/10.21315/mjps2023.21.2.3","url":null,"abstract":"Pharmacists can contribute to the improvement in diabetes management and help patients recognise and manage barriers to optimal medication adherence. Home medication review (HMR) services provided by pharmacists could also assist patients in minimising drugrelated problems. This systematic review aimed to evaluate and summarise evidence from recent literature on the effectiveness of pharmacist-led home medication review interventions to improve medication adherence in adult type-2 diabetes mellitus (T2DM) patients. Primary research articles published in English from 1st January 2012 to 31st May 2022, were retrieved from five online electronic databases (MEDLINE, Embase, Scopus, Cochrane Reviews and the Web of Science). The methodological quality of all included studies was assessed using the Critical Appraisal Skills Programme (CASP) checklists. The literature search identified 2,178 publications; only four were included in this review. All four studies found that pharmacist-led HMR was associated with significant positive changes in the patient’s medication adherence. Significant improvements were demonstrated either through self-reported medication adherence assessment questionnaires or the pill counting adherence ratio before and after HMR visits. There was evidence of statistically significant effectiveness of pharmacist-led HMR initiatives to improve patient adherence to medication among adult T2DM patients.","PeriodicalId":53358,"journal":{"name":"Malaysian Journal of Pharmaceutical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139244582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DELIVERY OF TRAINING IN HIV/AIDS SERVICES AMONG COMMUNITY PHARMACISTS IN OYO STATE, NIGERIA: AN INTERVENTIONAL STUDY 在尼日利亚奥约州社区药剂师中开展艾滋病毒/艾滋病服务培训:一项干预性研究
Pub Date : 2023-11-23 DOI: 10.21315/mjps2023.21.2.2
Y. Oseni, W. Erhun
A recent baseline study showed that community pharmacists’ involvement in HIV/AIDS services in Oyo State, Nigeria was low while respondents showed willingness to participate in training to improve services. This study assessed the training programme delivered to same respondents with the aim of improving HIV/AIDS services at the pharmacies. A one-day training was developed and delivered to 70 selected community pharmacists in Oyo State, Nigeria. Semi-structured questionnaire on a 5-point Likert scale was administered to the respondents to assess their opinion on the training, evaluate the resource persons and perceive sufficiency of the training to provide services. Data were analysed using IBM SPSS version 21.0 with descriptive statistics while open-ended responses were thematically analysed. Response rate was 71.4%. The mean score of participants’ opinion on the training program based on 10 indicators identified was 45.98 ± 5.177 (range of 10–50; midpoint 30). Lowest (21.21 ± 3.168) and highest (23.46 ± 2.510) scores were obtained (range 5–25; midpoint 15) based on the lecture presentation using 5-item measures for the resource persons. All the respondents agreed that the training will be sufficient to carry out the HIV/ AIDS services in their premises. Community pharmacists were satisfied with the training delivered, the resource persons were competent to deliver the training and that the training will be sufficient to deliver HIV/AIDS services in their pharmacies. Further study will evaluate the effect of the training on the HIV/AIDS services delivered by community pharmacists using the same participants.
最近的一项基线研究表明,尼日利亚奥约州的社区药剂师参与艾滋病防治服务的程度很低,但受访者表示愿意参加培训以改善服务。本研究评估了为同样的受访者提供的培训计划,目的是改善药房的艾滋病毒/艾滋病服务。在尼日利亚奥约州为 70 名选定的社区药剂师制定并提供了为期一天的培训。对受访者进行了 5 点李克特量表的半结构式问卷调查,以评估他们对培训的意见、对专家的评价以及对培训是否足以提供服务的看法。数据使用 IBM SPSS 21.0 版进行了描述性统计分析,并对开放式回答进行了主题分析。回复率为 71.4%。根据确定的 10 项指标,参与者对培训计划的意见平均得分为 45.98 ± 5.177(范围为 10-50;中间值为 30)。根据对专家的讲座介绍,采用 5 个项目的衡量标准,得到了最低分(21.21 ± 3.168)和最高分(23.46 ± 2.510)(范围为 5-25;中点为 15)。所有受访者都认为培训足以在他们的场所开展艾滋病服务。社区药剂师对所提供的培训表示满意,认为专家能够胜任培训工作,而且培训足以在他们的药房提供艾滋病服务。进一步的研究将使用相同的参与者,评估培训对社区药剂师提供艾滋病毒/艾滋病服务的影响。
{"title":"DELIVERY OF TRAINING IN HIV/AIDS SERVICES AMONG COMMUNITY PHARMACISTS IN OYO STATE, NIGERIA: AN INTERVENTIONAL STUDY","authors":"Y. Oseni, W. Erhun","doi":"10.21315/mjps2023.21.2.2","DOIUrl":"https://doi.org/10.21315/mjps2023.21.2.2","url":null,"abstract":"A recent baseline study showed that community pharmacists’ involvement in HIV/AIDS services in Oyo State, Nigeria was low while respondents showed willingness to participate in training to improve services. This study assessed the training programme delivered to same respondents with the aim of improving HIV/AIDS services at the pharmacies. A one-day training was developed and delivered to 70 selected community pharmacists in Oyo State, Nigeria. Semi-structured questionnaire on a 5-point Likert scale was administered to the respondents to assess their opinion on the training, evaluate the resource persons and perceive sufficiency of the training to provide services. Data were analysed using IBM SPSS version 21.0 with descriptive statistics while open-ended responses were thematically analysed. Response rate was 71.4%. The mean score of participants’ opinion on the training program based on 10 indicators identified was 45.98 ± 5.177 (range of 10–50; midpoint 30). Lowest (21.21 ± 3.168) and highest (23.46 ± 2.510) scores were obtained (range 5–25; midpoint 15) based on the lecture presentation using 5-item measures for the resource persons. All the respondents agreed that the training will be sufficient to carry out the HIV/ AIDS services in their premises. Community pharmacists were satisfied with the training delivered, the resource persons were competent to deliver the training and that the training will be sufficient to deliver HIV/AIDS services in their pharmacies. Further study will evaluate the effect of the training on the HIV/AIDS services delivered by community pharmacists using the same participants.","PeriodicalId":53358,"journal":{"name":"Malaysian Journal of Pharmaceutical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139243967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AN OVERVIEW ON CUBOSOMES AS REMARKABLE NANOCARRIER FOR DRUG DELIVERY 综述立方体作为药物输送的非凡纳米载体
Pub Date : 2023-11-23 DOI: 10.21315/mjps2023.21.2.4
Vandana Gupta
Lipids have been extensively used as main ingredients in various drug delivery systems, such as liposomes, solid lipid nanoparticles, nanostructured lipid carriers and lipid-based lyotropic liquid crystals. Over the past few years, lipid-based lyotropic, bicontinuous cubic phase liquid crystals have been investigated for their applicability to controlled delivery of active ingredients. Lipid-based lyotropic liquid crystals have highly ordered, thermodynamically stable internal nanostructure, thereby offering the potential as a sustained drug release matrix. The emulsification of cubic lipid phases in water results in the production of cubosomes that can be defined as nanoparticulate disperse systems characterised by high biocompatibility and bioadhesivity. The unique microstructure of cubosomes have the potentials to control the release of active ingredients, improve drug bioavailability and reduce toxicity, enhance the stability of drugs and to increase the penetrability of drug after topical application. This reflection will provide an overview of the lipids used to prepare cubic phase at physiological temperature, as well as the influencing factors on the phase transition of liquid crystals. In particular, the most current research progresses on cubic phase as drug delivery systems and its applications will be discussed. It might act as smart lipid nanoparticles for drug delivery.
脂质已被广泛用作各种给药系统的主要成分,如脂质体、固体脂质纳米颗粒、纳米结构脂质载体和脂基冻融液晶。过去几年来,人们一直在研究脂基各向同性双连续立方相液晶在控制活性成分给药方面的适用性。脂基各向同性液晶具有高度有序、热力学稳定的内部纳米结构,因此具有作为药物持续释放基质的潜力。立方体脂相在水中乳化后会产生立方体,这种立方体可定义为纳米颗粒分散系统,具有很高的生物相容性和生物粘附性。立方体独特的微观结构具有控制活性成分释放、提高药物生物利用度和降低毒性、增强药物稳定性以及提高局部用药后药物渗透性的潜力。本论文将概述在生理温度下用于制备立方相的脂质,以及液晶相变的影响因素。特别是,将讨论立方相作为药物输送系统的最新研究进展及其应用。它可以作为智能脂质纳米颗粒用于药物输送。
{"title":"AN OVERVIEW ON CUBOSOMES AS REMARKABLE NANOCARRIER FOR DRUG DELIVERY","authors":"Vandana Gupta","doi":"10.21315/mjps2023.21.2.4","DOIUrl":"https://doi.org/10.21315/mjps2023.21.2.4","url":null,"abstract":"Lipids have been extensively used as main ingredients in various drug delivery systems, such as liposomes, solid lipid nanoparticles, nanostructured lipid carriers and lipid-based lyotropic liquid crystals. Over the past few years, lipid-based lyotropic, bicontinuous cubic phase liquid crystals have been investigated for their applicability to controlled delivery of active ingredients. Lipid-based lyotropic liquid crystals have highly ordered, thermodynamically stable internal nanostructure, thereby offering the potential as a sustained drug release matrix. The emulsification of cubic lipid phases in water results in the production of cubosomes that can be defined as nanoparticulate disperse systems characterised by high biocompatibility and bioadhesivity. The unique microstructure of cubosomes have the potentials to control the release of active ingredients, improve drug bioavailability and reduce toxicity, enhance the stability of drugs and to increase the penetrability of drug after topical application. This reflection will provide an overview of the lipids used to prepare cubic phase at physiological temperature, as well as the influencing factors on the phase transition of liquid crystals. In particular, the most current research progresses on cubic phase as drug delivery systems and its applications will be discussed. It might act as smart lipid nanoparticles for drug delivery.","PeriodicalId":53358,"journal":{"name":"Malaysian Journal of Pharmaceutical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139245338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GLYCAEMIC CONTROL AND HYPOGLYCAEMIA AMONG PATIENTS WITH DIABETES IN A PHARMACIST-MANAGED INSULIN TITRATION PROGRAMME 药剂师管理的胰岛素滴定计划中糖尿病患者的血糖控制和低血糖情况
Pub Date : 2023-11-23 DOI: 10.21315/mjps2023.21.2.1
P. Lim, T. Wong, Yen Li Lim, Shueh Lin Lim, C. Lee
The impact of a pharmacist-managed insulin titration has never been systematically assessed among patients with diabetes. This study aimed to evaluate the impact of pharmacist-managed insulin titration on glycaemic control, total daily insulin dose, hypoglycaemia, hunger and body weight. Data was collected retrospectively from patients treated with insulin under the care of a pharmacist-managed insulin titration programme at the Diabetes and Endocrine Clinic, Hospital Pulau Pinang, Pulau Pinang, Malaysia. Patients who followed-up with pharmacists at one month to two months intervals and completed at least eight visits were included. Ninety-one patients (59.3% male) aged 50.82 ± 17.63 years old with 13.38 ± 8.88 years of diabetes were evaluated. Glycaemic control improved significantly from baseline to 4th month (–1.19%, p < 0.001) and 8th month (–1.37%, p < 0.001). Majority of patients were on twice daily premixed insulin (44.0%) followed by basal insulin (28.5%), basal bolus (18.7%) and thrice daily premixed insulin (8.8%). Total daily insulin dose increased significantly from baseline to 8th month among patients on basal insulin (0.24 ± 0.15 versus 0.29 ± 0.18 units/kg/day, p = 0.008) whereas the opposite was seen in patients treated fully on insulin (1.06 ± 0.48 units/kg/day versus 0.96 ± 0.37 units/kg/day, p = 0.005). Total hypoglycaemia and hunger episodes reduced significantly from 160 episodes/month to 30 episodes/month, p = 0.001 and 39 cases/month to 5 cases/ month, p < 0.001, respectively, across all groups. Mean weight increased by 0.66 kg from baseline to 8th month, p = 0.045. Insulin dose had a positive correlation to hypoglycaemia, r = 0.338, p = 0.001. Pharmacist-managed insulin titration programme significantly improved glycaemic control and reduced hypoglycaemia occurrences.
药剂师管理下的胰岛素滴定对糖尿病患者的影响从未进行过系统评估。本研究旨在评估由药剂师管理的胰岛素滴定对血糖控制、每日胰岛素总剂量、低血糖、饥饿感和体重的影响。研究人员通过回顾性方式收集了马来西亚普劳槟城普劳槟城医院糖尿病和内分泌诊所在药剂师管理的胰岛素滴定计划下接受胰岛素治疗的患者的数据。其中包括每隔一个月至两个月接受药剂师随访并完成至少八次随访的患者。接受评估的 91 名患者(59.3% 为男性)的年龄为 50.82 ± 17.63 岁,患糖尿病的时间为 13.38 ± 8.88 年。从基线到第 4 个月(-1.19%,p < 0.001)和第 8 个月(-1.37%,p < 0.001),血糖控制有了明显改善。大多数患者每天使用两次预混胰岛素(44.0%),其次是基础胰岛素(28.5%)、基础胰岛素(18.7%)和每天三次预混胰岛素(8.8%)。从基线到第 8 个月,使用基础胰岛素的患者每日胰岛素总剂量明显增加(0.24 ± 0.15 对 0.29 ± 0.18 单位/公斤/天,p = 0.008),而完全使用胰岛素的患者则相反(1.06 ± 0.48 单位/公斤/天对 0.96 ± 0.37 单位/公斤/天,p = 0.005)。各组的低血糖和饥饿发作次数分别从 160 次/月和 39 次/月大幅降至 30 次/月(p = 0.001)和 5 次/月(p < 0.001)。从基线到第 8 个月,平均体重增加了 0.66 千克,p = 0.045。胰岛素剂量与低血糖呈正相关,r = 0.338,p = 0.001。药剂师管理的胰岛素滴定计划明显改善了血糖控制并减少了低血糖的发生。
{"title":"GLYCAEMIC CONTROL AND HYPOGLYCAEMIA AMONG PATIENTS WITH DIABETES IN A PHARMACIST-MANAGED INSULIN TITRATION PROGRAMME","authors":"P. Lim, T. Wong, Yen Li Lim, Shueh Lin Lim, C. Lee","doi":"10.21315/mjps2023.21.2.1","DOIUrl":"https://doi.org/10.21315/mjps2023.21.2.1","url":null,"abstract":"The impact of a pharmacist-managed insulin titration has never been systematically assessed among patients with diabetes. This study aimed to evaluate the impact of pharmacist-managed insulin titration on glycaemic control, total daily insulin dose, hypoglycaemia, hunger and body weight. Data was collected retrospectively from patients treated with insulin under the care of a pharmacist-managed insulin titration programme at the Diabetes and Endocrine Clinic, Hospital Pulau Pinang, Pulau Pinang, Malaysia. Patients who followed-up with pharmacists at one month to two months intervals and completed at least eight visits were included. Ninety-one patients (59.3% male) aged 50.82 ± 17.63 years old with 13.38 ± 8.88 years of diabetes were evaluated. Glycaemic control improved significantly from baseline to 4th month (–1.19%, p < 0.001) and 8th month (–1.37%, p < 0.001). Majority of patients were on twice daily premixed insulin (44.0%) followed by basal insulin (28.5%), basal bolus (18.7%) and thrice daily premixed insulin (8.8%). Total daily insulin dose increased significantly from baseline to 8th month among patients on basal insulin (0.24 ± 0.15 versus 0.29 ± 0.18 units/kg/day, p = 0.008) whereas the opposite was seen in patients treated fully on insulin (1.06 ± 0.48 units/kg/day versus 0.96 ± 0.37 units/kg/day, p = 0.005). Total hypoglycaemia and hunger episodes reduced significantly from 160 episodes/month to 30 episodes/month, p = 0.001 and 39 cases/month to 5 cases/ month, p < 0.001, respectively, across all groups. Mean weight increased by 0.66 kg from baseline to 8th month, p = 0.045. Insulin dose had a positive correlation to hypoglycaemia, r = 0.338, p = 0.001. Pharmacist-managed insulin titration programme significantly improved glycaemic control and reduced hypoglycaemia occurrences.","PeriodicalId":53358,"journal":{"name":"Malaysian Journal of Pharmaceutical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139244012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Nationwide Survey on Malaysian Hospital Physicians’ Practices of Intravenous Potassium Chloride Supplementation and Opinions on Premixed Formulation in the Treatment of Hypokalaemia 马来西亚医院医生静脉补充氯化钾做法的全国调查及对预混制剂治疗低钾血症的意见
Pub Date : 2023-05-25 DOI: 10.21315/mjps2023.21.1.6
C. Chong, Melissa Mohammad Hirman
This study aims to evaluate the Malaysian hospital physicians’ practices of intravenous potassium chloride in the treatment of hypokalaemia and their opinions on using premixed formulation. This was a nationwide online survey using a self-administered questionnaire. The survey link was sent to the practising hospital physicians in Malaysia through email (n = 1,455), Facebook Messenger (n = 2,734) and posted on Facebook as well. A total of 207 responses were received. The physicians were mostly males (63.8%), aged between 30 years old–39 years old (51.2%) and worked in the government sectors (76.8%). The most preferred dosage of potassium chloride for mild, moderate and severe hypokalaemia was 10 mmol (44.4%), 20 mmol (55.1%) and 30 mmol (37.7%), respectively. The mostly chosen infusion rate of potassium chloride for mild hypokalaemia was over 24 h (41.1%) while for both moderate and severe hypokalaemia were over 1 h–2 h (63.8% and 89.9%, respectively). The concentration of intravenous potassium chloride is the main factor (68.1%) which would influence the infusion route choice. Serum potassium monitoring of every 24 h was chosen by 52.7% of the respondents for mild hypokalaemia while every 1 h–2 h was mostly chosen for moderate and severe hypokalaemia (49.3% and 87.4%, respectively). Cardiac monitoring was mostly opted in severe hypokalaemic patients (70.0%). Majority of physicians agreed that a premixed formulation is easier to administer (64.7%) and safer for the patients (51.7%). In conclusion, there were variations in the prescribing practices among Malaysian physicians to treat hypokalaemia. Most physicians were in favour of premixed formulation.
本研究旨在评估马来西亚医院医生静脉注射氯化钾治疗低钾血症的做法,以及他们对使用预混制剂的意见。这是一项全国性的在线调查,使用的是一份自我管理的问卷。调查链接通过电子邮件(n = 1,455)和Facebook Messenger (n = 2,734)发送给马来西亚的执业医院医生,并在Facebook上发布。我们共收到207份回应。医生以男性居多(63.8%),年龄介乎30至39岁(51.2%),在政府部门工作(76.8%)。轻度、中度和重度低钾血症患者首选氯化钾剂量分别为10 mmol(44.4%)、20 mmol(55.1%)和30 mmol(37.7%)。轻度低钾血症患者首选氯化钾输注时间超过24 h(41.1%),中度和重度低钾血症患者均选择输注时间超过1 h - 2 h(63.8%和89.9%)。静脉氯化钾浓度是影响输注途径选择的主要因素(68.1%)。对于轻度低钾血症,52.7%的受访者选择每24 h监测一次血钾,而对于中度和重度低钾血症,大多选择每1 h - 2 h监测一次(分别为49.3%和87.4%)。重度低钾血症患者多采用心脏监护(70.0%)。大多数医生认为预混制剂更容易管理(64.7%),对患者更安全(51.7%)。总之,马来西亚医生在治疗低钾血症的处方实践中存在差异。大多数医生赞成预混配方。
{"title":"A Nationwide Survey on Malaysian Hospital Physicians’ Practices of Intravenous Potassium Chloride Supplementation and Opinions on Premixed Formulation in the Treatment of Hypokalaemia","authors":"C. Chong, Melissa Mohammad Hirman","doi":"10.21315/mjps2023.21.1.6","DOIUrl":"https://doi.org/10.21315/mjps2023.21.1.6","url":null,"abstract":"This study aims to evaluate the Malaysian hospital physicians’ practices of intravenous potassium chloride in the treatment of hypokalaemia and their opinions on using premixed formulation. This was a nationwide online survey using a self-administered questionnaire. The survey link was sent to the practising hospital physicians in Malaysia through email (n = 1,455), Facebook Messenger (n = 2,734) and posted on Facebook as well. A total of 207 responses were received. The physicians were mostly males (63.8%), aged between 30 years old–39 years old (51.2%) and worked in the government sectors (76.8%). The most preferred dosage of potassium chloride for mild, moderate and severe hypokalaemia was 10 mmol (44.4%), 20 mmol (55.1%) and 30 mmol (37.7%), respectively. The mostly chosen infusion rate of potassium chloride for mild hypokalaemia was over 24 h (41.1%) while for both moderate and severe hypokalaemia were over 1 h–2 h (63.8% and 89.9%, respectively). The concentration of intravenous potassium chloride is the main factor (68.1%) which would influence the infusion route choice. Serum potassium monitoring of every 24 h was chosen by 52.7% of the respondents for mild hypokalaemia while every 1 h–2 h was mostly chosen for moderate and severe hypokalaemia (49.3% and 87.4%, respectively). Cardiac monitoring was mostly opted in severe hypokalaemic patients (70.0%). Majority of physicians agreed that a premixed formulation is easier to administer (64.7%) and safer for the patients (51.7%). In conclusion, there were variations in the prescribing practices among Malaysian physicians to treat hypokalaemia. Most physicians were in favour of premixed formulation.","PeriodicalId":53358,"journal":{"name":"Malaysian Journal of Pharmaceutical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41524122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medication Non-Adherence and Cost Associated with Hospitalisation of Hypertensive In-Patients in a Tertiary Hospital, Southwestern Nigeria 尼日利亚西南部一家三级医院高血压患者的药物依从性和住院费用
Pub Date : 2023-05-25 DOI: 10.21315/mjps2023.21.1.4
Aduke Elizabeth Ipingbem, W. Erhun, R. Adisa
The study aimed at estimating the cost of hospitalisation associated with medication non-adherence (MNA) among hypertensive in-patients in a tertiary healthcare facility in southwestern Nigeria. It involved a cross-sectional retrospective review of 322 medical records of hypertensive in-patients at the University College Hospital between 2013 and 2015. Physician’s documentation of MNA in the patients’ medical records prior to admission determined the eligibility into the study. Direct medical costs mainly consultation, medications, laboratory costs for individual patients during hospitalisation were calculated using out-of-pocket payer’s perspective approach. Data were summarised with descriptive statistics, Pearson’s product moment correlation coefficient was used to determine relationship between length of stay in hospital, cost of management and number of comorbidities at p < 0.05 considered statistically significant. Of the 322 medical records of hypertensive in-patients evaluated within the 3-year study period, 230 (71.4%) had a documentation of MNA. The average age was 55.9 ± 15.7 years old. Artisans/self-employed (n = 82; 35.7%) and petty traders (n = 61; 26.5%) made up the majority of the patients. The total cost of hospitalisation for the period studied was USD100,461.40 for all the patients, with an average of USD52.00 ± 28.10/patient/day, more than a quarter of which was spent on pharmaceuticals. Similarly, the costs of management also increased with increase in length of hospitalisation (Pearson’s product moment correlation r = 0.539, p = 0.000). The number of comorbid diseases increased the length of hospitalisation (r = 0.133, p = 0.044). Cost associated with hospitalisation in relation to MNA is high among the studied participants. There is a need to develop strategies to enhance medication adherence among patients with hypertension.
该研究旨在估计尼日利亚西南部一家三级医疗机构中高血压住院患者与药物依从性(MNA)相关的住院费用。该研究对2013年至2015年间大学学院医院322例高血压住院患者的病历进行了横断面回顾性分析。医生在患者入院前的医疗记录中记录的MNA决定了是否有资格进入研究。直接医疗费用,主要是个别患者住院期间的咨询、药物、化验费,采用自付视角计算。采用描述性统计对资料进行汇总,采用Pearson积差相关系数确定住院时间、管理费用和合并症数量之间的关系,p < 0.05认为有统计学意义。在3年研究期间评估的322例高血压住院患者的医疗记录中,230例(71.4%)有MNA的记录。平均年龄55.9±15.7岁。工匠/自雇人士(82名;35.7%)和小商贩(n = 61;26.5%)占多数。在研究期间,所有患者的住院总费用为100,461.40美元,平均为52.00±28.10美元/患者/天,其中超过四分之一用于药物。同样,管理费用也随着住院时间的增加而增加(Pearson积差相关r = 0.539, p = 0.000)。合并症的数量增加了住院时间(r = 0.133, p = 0.044)。与MNA相关的住院费用在研究参与者中较高。有必要制定策略,以提高高血压患者的药物依从性。
{"title":"Medication Non-Adherence and Cost Associated with Hospitalisation of Hypertensive In-Patients in a Tertiary Hospital, Southwestern Nigeria","authors":"Aduke Elizabeth Ipingbem, W. Erhun, R. Adisa","doi":"10.21315/mjps2023.21.1.4","DOIUrl":"https://doi.org/10.21315/mjps2023.21.1.4","url":null,"abstract":"The study aimed at estimating the cost of hospitalisation associated with medication non-adherence (MNA) among hypertensive in-patients in a tertiary healthcare facility in southwestern Nigeria. It involved a cross-sectional retrospective review of 322 medical records of hypertensive in-patients at the University College Hospital between 2013 and 2015. Physician’s documentation of MNA in the patients’ medical records prior to admission determined the eligibility into the study. Direct medical costs mainly consultation, medications, laboratory costs for individual patients during hospitalisation were calculated using out-of-pocket payer’s perspective approach. Data were summarised with descriptive statistics, Pearson’s product moment correlation coefficient was used to determine relationship between length of stay in hospital, cost of management and number of comorbidities at p < 0.05 considered statistically significant. Of the 322 medical records of hypertensive in-patients evaluated within the 3-year study period, 230 (71.4%) had a documentation of MNA. The average age was 55.9 ± 15.7 years old. Artisans/self-employed (n = 82; 35.7%) and petty traders (n = 61; 26.5%) made up the majority of the patients. The total cost of hospitalisation for the period studied was USD100,461.40 for all the patients, with an average of USD52.00 ± 28.10/patient/day, more than a quarter of which was spent on pharmaceuticals. Similarly, the costs of management also increased with increase in length of hospitalisation (Pearson’s product moment correlation r = 0.539, p = 0.000). The number of comorbid diseases increased the length of hospitalisation (r = 0.133, p = 0.044). Cost associated with hospitalisation in relation to MNA is high among the studied participants. There is a need to develop strategies to enhance medication adherence among patients with hypertension.","PeriodicalId":53358,"journal":{"name":"Malaysian Journal of Pharmaceutical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43333113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chromatography-Spectroscopic Isolated MO11 (Moringa oleifera) and MS06 (Musa sapientum) Positively Immunomodulated ACE2 Levels in Blood, Kidney and Liver of Rats 色谱光谱法分离的MO11(辣木)和MS06(武藏)对大鼠血液、肾脏和肝脏中ACE2水平的免疫调节作用
Pub Date : 2023-05-25 DOI: 10.21315/mjps20223.21.1.2
Mubarak O. Ameen, Adelaja A. Akinlolu
Moringa oleifera (MO) and Musa sapientum (MS) are ethno-medicinal plants, while cadmium is a carcinogen. SARS-CoV-2 binds to ACE2 for host’s cell invasion and infection. This study evaluated the effects of MO11 (isolated from MO leaves) and MS06 (isolated from MS suckers) on ACE2 levels in cadmium chloride (CdCl)-induced toxicity in rats. Twentyfour adult male Wistar rats were randomly divided into six groups (n = 4). Group 1 was control. Groups 2–4 received single 1.5 mg/kg bodyweight of CdCl (i.p.) (Day 1). Groups 3 and 4 were post-treated with MO11 and MO11 + MS06 doses, respectively (Days 1–17). Groups 5 and 6 received only MO11 and olive oil (vehicle), respectively (Days 1–17). MO leaves and MS suckers were subjected to bioassay-guided fractionation and isolation procedures using chromatography and spectroscopic techniques. ACE2 levels (ELISA) were evaluated in blood, kidney and liver of rats. MO11 and MS06 were the most active antioxidant and antimicrobial compounds isolated from MO leaves and MS suckers, respectively. Liquid chromatography-mass spectrometry showed presence of therapeutic compounds and amino-acids in MO11 and MS06, which are part of 14 shared amino-acids used by SARS-CoV and SARS-CoV-2 for ACE2-binding. Post-treatments of CdCl-exposure with MO11 and MS06 showed decreased ACE2 levels in Group 4 (20.63 ± 4.33 ng/mL and 16.11 ± 0.49 ng/mL in blood and kidney samples, respectively), compared with Group 2 (39.39 ± 3.15 ng/mL and 85.39 ± 3.10 ng/mL in blood and kidney samples, respectively). In conclusion, MO11 and MS06 possess significant ethno-medicinal potentials, may compete with SARS-CoV-2 for ACE2 binding, and are recommended for evaluations as anti-SARS-CoV-2 agents.
辣木(MO)和木犀(MS)是民族药用植物,而镉是致癌物质。严重急性呼吸系统综合征冠状病毒2型与ACE2结合,用于宿主细胞入侵和感染。本研究评估了MO11(从MO叶中分离)和MS06(从MS吸盘中分离)对氯化镉(CdCl)诱导的大鼠毒性中ACE2水平的影响。将24只成年雄性Wistar大鼠随机分为6组(n=4)。第1组为对照组。第2-4组接受1.5 mg/kg体重的CdCl(腹膜内注射)(第1天)。第3组和第4组分别用MO11和MO11+MS06剂量进行后处理(第1-17天)。第5组和第6组分别只接受了MO11和橄榄油(载体)(第1-17天)。使用色谱和光谱技术对MO叶和MS吸盘进行生物测定引导的分级和分离程序。检测大鼠血液、肾脏和肝脏中的ACE2水平(ELISA)。MO11和MS06分别是从MO叶和MS吸盘中分离出的最具活性的抗氧化和抗菌化合物。液相色谱-质谱分析显示,MO11和MS06中存在治疗性化合物和氨基酸,它们是严重急性呼吸系统综合征冠状病毒和严重急性呼吸综合征冠状病毒2型用于结合ACE2的14个共享氨基酸的一部分。与第2组(血液和肾脏样本分别为39.39±3.15 ng/mL和85.39±3.10 ng/mL)相比,用MO11和MS06处理CdCl暴露后,第4组的ACE2水平下降(血液和肾样本分别为20.63±4.33 ng/mL和16.11±0.49 ng/mL)。总之,MO11和MS06具有显著的民族药用潜力,可能与严重急性呼吸系统综合征冠状病毒2型竞争ACE2结合,并被推荐作为抗严重急性呼吸综合征冠状病毒二型药物进行评估。
{"title":"Chromatography-Spectroscopic Isolated MO11 (Moringa oleifera) and MS06 (Musa sapientum) Positively Immunomodulated ACE2 Levels in Blood, Kidney and Liver of Rats","authors":"Mubarak O. Ameen, Adelaja A. Akinlolu","doi":"10.21315/mjps20223.21.1.2","DOIUrl":"https://doi.org/10.21315/mjps20223.21.1.2","url":null,"abstract":"Moringa oleifera (MO) and Musa sapientum (MS) are ethno-medicinal plants, while cadmium is a carcinogen. SARS-CoV-2 binds to ACE2 for host’s cell invasion and infection. This study evaluated the effects of MO11 (isolated from MO leaves) and MS06 (isolated from MS suckers) on ACE2 levels in cadmium chloride (CdCl)-induced toxicity in rats. Twentyfour adult male Wistar rats were randomly divided into six groups (n = 4). Group 1 was control. Groups 2–4 received single 1.5 mg/kg bodyweight of CdCl (i.p.) (Day 1). Groups 3 and 4 were post-treated with MO11 and MO11 + MS06 doses, respectively (Days 1–17). Groups 5 and 6 received only MO11 and olive oil (vehicle), respectively (Days 1–17). MO leaves and MS suckers were subjected to bioassay-guided fractionation and isolation procedures using chromatography and spectroscopic techniques. ACE2 levels (ELISA) were evaluated in blood, kidney and liver of rats. MO11 and MS06 were the most active antioxidant and antimicrobial compounds isolated from MO leaves and MS suckers, respectively. Liquid chromatography-mass spectrometry showed presence of therapeutic compounds and amino-acids in MO11 and MS06, which are part of 14 shared amino-acids used by SARS-CoV and SARS-CoV-2 for ACE2-binding. Post-treatments of CdCl-exposure with MO11 and MS06 showed decreased ACE2 levels in Group 4 (20.63 ± 4.33 ng/mL and 16.11 ± 0.49 ng/mL in blood and kidney samples, respectively), compared with Group 2 (39.39 ± 3.15 ng/mL and 85.39 ± 3.10 ng/mL in blood and kidney samples, respectively). In conclusion, MO11 and MS06 possess significant ethno-medicinal potentials, may compete with SARS-CoV-2 for ACE2 binding, and are recommended for evaluations as anti-SARS-CoV-2 agents.","PeriodicalId":53358,"journal":{"name":"Malaysian Journal of Pharmaceutical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49659689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of Knowledge and Counseling on Metered-Dose Inhalers and Nebulisers among Community Pharmacists in Ibadan - An Intervention Study 伊巴丹市社区药师计量吸入器和雾化器知识及咨询评价——一项干预研究
Pub Date : 2023-05-25 DOI: 10.21315/mjps2023.21.1.8
A. A. Aje, Taiwo Abiola Adekunle
This study evaluated the impact of an educational intervention on knowledge and counseling on metered-dose inhalers (MDIs) and nebulisers among community pharmacists in Ibadan, Nigeria. A validated semi-structured questionnaire was utilised for data collection on study participants’ baseline knowledge and counseling on the selected asthma medication devices. The community pharmacists were randomised into control and intervention groups. An online educational intervention was carried out among pharmacists in the intervention group. The intervention comprised updates on basic information vis-à-vis knowledge and patient counseling on MDIs and nebulisers. A post-intervention assessment was carried out a month later to evaluate the impact of the intervention. Data was summarised using descriptive and inferential statistics, with level of significance set as p < 0.05. Response rate was 77.2% (112/145). Study findings showed significant improvement on knowledge and counseling among the community pharmacists in the intervention group, postintervention. Pharmacists’ knowledge of MDIs and nebulisers (control versus intervention) was comparable at baseline (5.83 ± 2.46 versus 6.34 ± 2.16) but significantly different postintervention (5.87 ± 2.34 versus 7.10 ± 2.21). Similarly, pharmacists’ counselling on asthma medication devices was comparable at baseline (3.59 ± 2.54 versus 3.63 ± 1.83) but significantly different postintervention (3.35 ± 3.13 versus 7.93 ± 2.58). Work experience as community pharmacists did not influence participants’ knowledge and counseling on MDIs and nebulisers. The educational intervention significantly improved knowledge and counseling on MDIs and nebulisers among community pharmacists in Ibadan, Nigeria. There is need for regular educational updates to improve the quality of care offered by community pharmacists.
本研究评估了教育干预对尼日利亚伊巴丹社区药剂师对计量吸入器(MDIs)和雾化器的知识和咨询的影响。一份经过验证的半结构化问卷用于收集研究参与者对所选哮喘药物装置的基线知识和咨询的数据。将社区药师随机分为对照组和干预组。对干预组药师进行在线教育干预。干预措施包括更新基本信息,如-à-vis知识和对吸入吸入器和雾化器的患者咨询。一个月后进行干预后评估,以评估干预的影响。数据汇总采用描述性统计和推理统计,显著性水平设置为p < 0.05。有效率为77.2%(112/145)。研究发现,干预组社区药师的知识和咨询在干预后有显著改善。基线时,对照与干预组药师对MDIs和雾化器的了解程度相当(5.83±2.46 vs 6.34±2.16),但干预后差异显著(5.87±2.34 vs 7.10±2.21)。同样,药师对哮喘药物装置的咨询在基线时具有可比性(3.59±2.54 vs 3.63±1.83),但干预后差异显著(3.35±3.13 vs 7.93±2.58)。作为社区药剂师的工作经验不影响参与者对MDIs和雾化器的知识和咨询。教育干预显著提高了尼日利亚伊巴丹社区药剂师对计量吸入器和雾化器的了解和咨询。有必要定期更新教育,以提高社区药剂师提供的护理质量。
{"title":"Evaluation of Knowledge and Counseling on Metered-Dose Inhalers and Nebulisers among Community Pharmacists in Ibadan - An Intervention Study","authors":"A. A. Aje, Taiwo Abiola Adekunle","doi":"10.21315/mjps2023.21.1.8","DOIUrl":"https://doi.org/10.21315/mjps2023.21.1.8","url":null,"abstract":"This study evaluated the impact of an educational intervention on knowledge and counseling on metered-dose inhalers (MDIs) and nebulisers among community pharmacists in Ibadan, Nigeria. A validated semi-structured questionnaire was utilised for data collection on study participants’ baseline knowledge and counseling on the selected asthma medication devices. The community pharmacists were randomised into control and intervention groups. An online educational intervention was carried out among pharmacists in the intervention group. The intervention comprised updates on basic information vis-à-vis knowledge and patient counseling on MDIs and nebulisers. A post-intervention assessment was carried out a month later to evaluate the impact of the intervention. Data was summarised using descriptive and inferential statistics, with level of significance set as p < 0.05. Response rate was 77.2% (112/145). Study findings showed significant improvement on knowledge and counseling among the community pharmacists in the intervention group, postintervention. Pharmacists’ knowledge of MDIs and nebulisers (control versus intervention) was comparable at baseline (5.83 ± 2.46 versus 6.34 ± 2.16) but significantly different postintervention (5.87 ± 2.34 versus 7.10 ± 2.21). Similarly, pharmacists’ counselling on asthma medication devices was comparable at baseline (3.59 ± 2.54 versus 3.63 ± 1.83) but significantly different postintervention (3.35 ± 3.13 versus 7.93 ± 2.58). Work experience as community pharmacists did not influence participants’ knowledge and counseling on MDIs and nebulisers. The educational intervention significantly improved knowledge and counseling on MDIs and nebulisers among community pharmacists in Ibadan, Nigeria. There is need for regular educational updates to improve the quality of care offered by community pharmacists.","PeriodicalId":53358,"journal":{"name":"Malaysian Journal of Pharmaceutical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46548203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Direct Compression Properties of Co-Processed Excipient Containing Cow Bone Powder, Khaya Gum and Maize Starch 牛骨粉、卡亚胶和玉米淀粉共加工赋形剂的直接压缩性能
Pub Date : 2023-05-25 DOI: 10.21315/mjps2023.21.1.7
Yohanah Dauda Yerima, A. Isah, A. Oyi, Aliyu Muhammad Musa, Y. Apeji
The aim of this study was to evaluate the direct compression properties of a novel coprocessed excipient (CPE) generated by processing cow bone powder (CBP), maize starch (MS) and Khaya gum (KG) together to form a single composite excipient. Design of experiments (DoE) was employed to optimise the formulation of CPE. CPE was prepared by wet granulation using the optimised formulation of CBP (40%), MS (40%) and KG (20%) as recommended by DoE. Assessment of the organoleptic properties of CPE revealed an odourless, tasteless and coarse texture with a neutral pH of 7.3. CPE was found to be partly crystalline and partly amorphous and demonstrated compatibility between the three components of the formulation. The material in terms of flowability compared well with the flow parameters of StarLac, a reference co-processed excipient. Tablets of diclofenac produced by direct compression using CPE as the directly compressible excipient compared well with the hardness and disintegration time of tablets made using StarLac® as the directly compressible excipient. The study’s outcome shows that CPE can be used as a direct compression excipient in the formulation of tablets by direct compression.
本研究的目的是评估一种新型共处理赋形剂(CPE)的直接压缩性能,该赋形剂是通过将牛骨粉(CBP)、玉米淀粉(MS)和卡亚胶(KG)一起加工形成单一的复合赋形剂而产生的。采用实验设计(DoE)优化CPE的配方。CPE通过湿法造粒制备,使用DoE推荐的CBP(40%)、MS(40%)和KG(20%)的优化配方。CPE的感官特性评估显示其无臭、无味、质地粗糙,中性pH值为7.3。CPE被发现是部分结晶和部分无定形的,并且证明了制剂的三种组分之间的相容性。该材料在流动性方面与参考共处理赋形剂StarLac的流动参数进行了很好的比较。使用CPE作为直接可压缩赋形剂通过直接压缩生产的双氯芬酸片剂与使用StarLac®作为直接可挤压赋形剂生产的片剂的硬度和崩解时间进行了很好的比较。研究结果表明,CPE可作为直接压片辅料用于片剂的直接压片。
{"title":"Direct Compression Properties of Co-Processed Excipient Containing Cow Bone Powder, Khaya Gum and Maize Starch","authors":"Yohanah Dauda Yerima, A. Isah, A. Oyi, Aliyu Muhammad Musa, Y. Apeji","doi":"10.21315/mjps2023.21.1.7","DOIUrl":"https://doi.org/10.21315/mjps2023.21.1.7","url":null,"abstract":"The aim of this study was to evaluate the direct compression properties of a novel coprocessed excipient (CPE) generated by processing cow bone powder (CBP), maize starch (MS) and Khaya gum (KG) together to form a single composite excipient. Design of experiments (DoE) was employed to optimise the formulation of CPE. CPE was prepared by wet granulation using the optimised formulation of CBP (40%), MS (40%) and KG (20%) as recommended by DoE. Assessment of the organoleptic properties of CPE revealed an odourless, tasteless and coarse texture with a neutral pH of 7.3. CPE was found to be partly crystalline and partly amorphous and demonstrated compatibility between the three components of the formulation. The material in terms of flowability compared well with the flow parameters of StarLac, a reference co-processed excipient. Tablets of diclofenac produced by direct compression using CPE as the directly compressible excipient compared well with the hardness and disintegration time of tablets made using StarLac® as the directly compressible excipient. The study’s outcome shows that CPE can be used as a direct compression excipient in the formulation of tablets by direct compression.","PeriodicalId":53358,"journal":{"name":"Malaysian Journal of Pharmaceutical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45888825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Antimicrobial Stewardship Programme on Antimicrobial Utilisation, Cost and Bacterial Resistance in a Malaysian Public Tertiary Hospital 抗菌药物管理方案对马来西亚公立三级医院抗菌药物使用、成本和细菌耐药性的影响
Pub Date : 2023-05-25 DOI: 10.21315/mjps2023.21.1.3
Azrina Abdul Aziz, C. Chong, Najihah Idris, Wan Alifah Wan Ismail, Hamimah Saidin
Antimicrobial stewardship programme (ASP) was introduced as one of the strategies to curb the rise of multi-drug resistant (MDR) organism. The findings on the programme establishment are important in strengthening ASP measures. This study aimed to assess the impact of ASP implementation on the antimicrobial utilisation, antimicrobial cost and the MDR bacterial resistant rate before and after the programme initiation. A retrospective cohort study involving adult inpatient in a public tertiary hospital was conducted between pre-ASP implementation in year 2015 and post-ASP implementation from year 2016 to 2019. The statistical analysis of Student t-test or Mann-Whitney U test was used depending on the data distribution. The mean defined daily dose (DDD) per 1,000 patient days for ASP targeted antibiotics was significantly decreased by 17% from 161.52 DDD per 1,000 patient days in pre-ASP period to 134.49 DDD per 1,000 patient days in post-ASP period mainly from the usage of third generation cephalosporin, carbapenem and colistin. The annual expenditure for ASP targeted antibiotics had significant monetary reduction from RM30,580.50 in pre-ASP period to RM20,590.60 during post-ASP period. Significant reduction in the mean MDR bacterial resistant rate were notable for extended spectrum beta-lactamase E. coli (27.48%–17.85%), methicillin-resistant Staphylococcus aureus (22.25%–15.73%) and MDR Acinetobacter spp. (71.46%–49.34%). The implementation of ASP leads to significant reduction on the ASP targeted antibiotics utilisation, antimicrobial cost and MDR bacterial resistance rate. These outcomes are beneficial in justification and expansion of ASP activities in Malaysia.
抗菌药物管理计划(ASP)是遏制耐多药(MDR)生物增加的策略之一。关于方案制定的调查结果对于加强ASP措施非常重要。本研究旨在评估项目启动前后ASP实施对抗菌药物利用率、抗菌药物成本和耐多药细菌耐药率的影响。在2015年ASP实施前和2016年至2019年ASP实施后期间,对公立三级医院的成年住院患者进行了一项回顾性队列研究。根据数据分布使用Student t检验或Mann-Whitney U检验的统计分析。主要由于使用第三代头孢菌素、碳青霉烯和粘菌素,ASP靶向抗生素的平均限定日剂量(DDD)从ASP前的161.52 DDD每1000患者日显著降低了17%,从ASP后的134.49 DDD每000患者日。ASP靶向抗生素的年度支出从ASP前的30580.50令吉大幅减少到ASP后的20590.60令吉。超广谱β-内酰胺酶大肠杆菌(27.48%–17.85%)、耐甲氧西林金黄色葡萄球菌(22.25%–15.73%)和耐多药不动杆菌属(71.46%–49.34%)的平均耐多药细菌耐药率显著降低,抗菌成本和耐多药耐药率。这些结果有利于证明和扩大ASP在马来西亚的活动。
{"title":"Impact of Antimicrobial Stewardship Programme on Antimicrobial Utilisation, Cost and Bacterial Resistance in a Malaysian Public Tertiary Hospital","authors":"Azrina Abdul Aziz, C. Chong, Najihah Idris, Wan Alifah Wan Ismail, Hamimah Saidin","doi":"10.21315/mjps2023.21.1.3","DOIUrl":"https://doi.org/10.21315/mjps2023.21.1.3","url":null,"abstract":"Antimicrobial stewardship programme (ASP) was introduced as one of the strategies to curb the rise of multi-drug resistant (MDR) organism. The findings on the programme establishment are important in strengthening ASP measures. This study aimed to assess the impact of ASP implementation on the antimicrobial utilisation, antimicrobial cost and the MDR bacterial resistant rate before and after the programme initiation. A retrospective cohort study involving adult inpatient in a public tertiary hospital was conducted between pre-ASP implementation in year 2015 and post-ASP implementation from year 2016 to 2019. The statistical analysis of Student t-test or Mann-Whitney U test was used depending on the data distribution. The mean defined daily dose (DDD) per 1,000 patient days for ASP targeted antibiotics was significantly decreased by 17% from 161.52 DDD per 1,000 patient days in pre-ASP period to 134.49 DDD per 1,000 patient days in post-ASP period mainly from the usage of third generation cephalosporin, carbapenem and colistin. The annual expenditure for ASP targeted antibiotics had significant monetary reduction from RM30,580.50 in pre-ASP period to RM20,590.60 during post-ASP period. Significant reduction in the mean MDR bacterial resistant rate were notable for extended spectrum beta-lactamase E. coli (27.48%–17.85%), methicillin-resistant Staphylococcus aureus (22.25%–15.73%) and MDR Acinetobacter spp. (71.46%–49.34%). The implementation of ASP leads to significant reduction on the ASP targeted antibiotics utilisation, antimicrobial cost and MDR bacterial resistance rate. These outcomes are beneficial in justification and expansion of ASP activities in Malaysia.","PeriodicalId":53358,"journal":{"name":"Malaysian Journal of Pharmaceutical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42792611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Malaysian Journal of Pharmaceutical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1